Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Moharram, Sausan A., Shah, Kinjal, Khanum, Fatima, Rönnstrand, Lars, Kazi, Julhash U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658549/
https://www.ncbi.nlm.nih.gov/pubmed/31346159
http://dx.doi.org/10.1038/s41408-019-0214-8
_version_ 1783438979200188416
author Moharram, Sausan A.
Shah, Kinjal
Khanum, Fatima
Rönnstrand, Lars
Kazi, Julhash U.
author_facet Moharram, Sausan A.
Shah, Kinjal
Khanum, Fatima
Rönnstrand, Lars
Kazi, Julhash U.
author_sort Moharram, Sausan A.
collection PubMed
description
format Online
Article
Text
id pubmed-6658549
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-66585492019-07-29 Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia Moharram, Sausan A. Shah, Kinjal Khanum, Fatima Rönnstrand, Lars Kazi, Julhash U. Blood Cancer J Correction Nature Publishing Group UK 2019-07-25 /pmc/articles/PMC6658549/ /pubmed/31346159 http://dx.doi.org/10.1038/s41408-019-0214-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Moharram, Sausan A.
Shah, Kinjal
Khanum, Fatima
Rönnstrand, Lars
Kazi, Julhash U.
Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
title Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
title_full Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
title_fullStr Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
title_full_unstemmed Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
title_short Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
title_sort correction: the alk inhibitor azd3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658549/
https://www.ncbi.nlm.nih.gov/pubmed/31346159
http://dx.doi.org/10.1038/s41408-019-0214-8
work_keys_str_mv AT moharramsausana correctionthealkinhibitorazd3463effectivelyinhibitsgrowthofsorafenibresistantacutemyeloidleukemia
AT shahkinjal correctionthealkinhibitorazd3463effectivelyinhibitsgrowthofsorafenibresistantacutemyeloidleukemia
AT khanumfatima correctionthealkinhibitorazd3463effectivelyinhibitsgrowthofsorafenibresistantacutemyeloidleukemia
AT ronnstrandlars correctionthealkinhibitorazd3463effectivelyinhibitsgrowthofsorafenibresistantacutemyeloidleukemia
AT kazijulhashu correctionthealkinhibitorazd3463effectivelyinhibitsgrowthofsorafenibresistantacutemyeloidleukemia

Ejemplares similares